Market Tracker

11/21 6:05pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

145.37
Data as of Nov 21
 +2.69 / +1.89%
Today’s Change
105.17
Today|||52-Week Range
153.10
+23.82%
Year-to-Date

Today’s Trading

Previous close142.68
Today’s open144.28
Day’s range143.06 - 146.58
Volume2,258,349
Average volume (3 months)2,657,570
Market cap$47.9B
Dividend yield--
Data as of 4:01pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+32.30%
Earnings growth (next 5 years)+33.90%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book9.28

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC-1.14-0.54%
ALXNAlexion Pharmaceutic...-1.53-0.79%
AGNAllergan Inc-1.11-0.53%
ABTAbbott Laboratories+0.03+0.07%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$2.49
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts